Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,74 USD | -3,01% | -12,34% | -8,29% |
02/04 | Voyager Therapeutics, Inc. Benoemt Robin Swartz tot hoofd boekhouding | CI |
26/03 | VOYAGER THERAPEUTICS, INC. : Guggenheim handhaaft koopadvies | ZM |
Omzet 2024 * | 38,84 mln. 36,38 mln. | Omzet 2025 * | 51,19 mln. 47,94 mln. | Marktkapitalisatie | 420 mln. 394 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -98 mln. -91,79 mln. | Nettowinst (verlies) 2025 * | -106 mln. -99,28 mln. | EV/omzet 2024 * | 2,68 x |
Nettoliquiditeiten 2024 * | 316 mln. 296 mln. | Nettoliquiditeiten 2025 * | 373 mln. 350 mln. | EV/omzet 2025 * | 0,92 x |
K/w-verhouding 2024 * |
-4,31
x | K/w-verhouding 2025 * |
-4,41
x | Werknemers | 162 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,71% |
Recentste transcriptie over Voyager Therapeutics, Inc.
1 dag | -3,01% | ||
1 week | -12,34% | ||
Lopende maand | -16,86% | ||
1 maand | -16,59% | ||
3 maanden | +6,03% | ||
6 maanden | +2,38% | ||
Lopend jaar | -8,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 01-03-22 |
Michael Higgins
CHM | Chairman | 61 | 22-07-15 |
Director of Finance/CFO | 55 | 19-09-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 09-05-23 |
James Geraghty
BRD | Director/Board Member | 70 | 01-01-14 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 05-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +1,25% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 7,74 | -3,01% | 785 424 |
16-04-24 | 7,98 | -3,16% | 398 336 |
15-04-24 | 8,24 | -2,25% | 450 425 |
12-04-24 | 8,43 | -3,99% | 565 057 |
11-04-24 | 8,78 | -0,57% | 426 084 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,29% | 420 mln. | |
-1,78% | 41,36 mld. | |
+45,38% | 41,3 mld. | |
+4,01% | 39,61 mld. | |
-15,14% | 25,62 mld. | |
+3,16% | 24,09 mld. | |
-24,08% | 18,38 mld. | |
-2,67% | 11,82 mld. | |
+24,76% | 11,85 mld. | |
+7,01% | 11,07 mld. |